High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.
Hiromi MatsumotoTaichi FukushimaNobuaki KobayashYuuki HigashinoSuguru MuraokaYukiko OhtsuMomo HirataKohei SomekawaAyami KanekoRyo NagasawaSousuke KuboKatsushi TanakaKota MurohashiHiroaki FujiiKeisuke WatanabeNobuyuki HoritaYu HaraTakeshi KanekoPublished in: PloS one (2024)
This study suggests the utility of CDWs in identifying prognostic biomarkers for ICI therapy in cancer treatment. Elevated RDW before treatment initiation emerged as a potential biomarker of shorter therapy duration.